Embecta Corp. EMBC
Set alert
6.25 USD -0.31 -4.73%
At close · Oct 30
6.25 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
6.20 Day range 6.55
2.90 52-week range 14.64
- YTD
- -47.39%
- 1 year
- -54.25%
- Open
- 6.55
- Prev close
- 6.56
- Mkt cap
- 354.12M
- Vol
- 831.10K
- Avg vol
- 1.29M
- EPS
- 1.47
- P/E
- 4.25
- Div yield
- 4.47%
More statistics
- Low
- 6.20
- High
- 6.55
- Forward P/E
- 5.95
- Beta
- 1.15
- Short ratio
- 4.13
- Inst. own
- 98.19%
- Dividend
- 0.60
- Ex-div date
- Feb 27, 2025
- Earnings
- Nov 26, 2024
- 50-d avg
- 18.31
- 200-d avg
- 15.47
- 1y target
- 22.00
1D chart
Signals (26)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | 3:57 PM | 2 days ago |
| RSI: Oversold | 3:57 PM | 2 days ago |
| MACD: Buy Signal | 3:49 PM | 2 days ago |
| RSI: Oversold | 3:32 PM | 2 days ago |
| SMA: Bearish | 3:27 PM | 2 days ago |
| SMA: Bearish | 3:27 PM | 2 days ago |
| MACD: Sell Signal | 3:22 PM | 2 days ago |
| RSI: Overbought | 3:18 PM | 2 days ago |
| RSI: Overbought | 3:01 PM | 2 days ago |
| RSI: Overbought | 2:46 PM | 2 days ago |
| MACD: Buy Signal | 2:27 PM | 2 days ago |
| MACD: Sell Signal | 2:18 PM | 2 days ago |
| SMA: Bullish | 2:01 PM | 2 days ago |
| MACD: Buy Signal | 1:52 PM | 2 days ago |
| RSI: Oversold | 1:47 PM | 2 days ago |
| MACD: Sell Signal | 1:20 PM | 2 days ago |
| MACD: Buy Signal | 1:19 PM | 2 days ago |
| MACD: Sell Signal | 1:06 PM | 2 days ago |
| MACD: Buy Signal | 1:02 PM | 2 days ago |
| MACD: Sell Signal | 12:32 PM | 2 days ago |
| MACD: Buy Signal | 12:15 PM | 2 days ago |
| MACD: Sell Signal | 11:34 AM | 3 days ago |
| RSI: Overbought | 11:14 AM | 3 days ago |
| RSI: Overbought | 11:12 AM | 3 days ago |
| MACD: Buy Signal | 10:44 AM | 3 days ago |
| SMA: Bearish | 10:13 AM | 3 days ago |
Key statistics
- Market cap
- 784.81M
- Enterprise value
- 2.16B
- Trailing P/E
- 13.64
- Forward P/E
- 5.95
- PEG ratio
- 0.00
- Price / sales
- 0.71
- Price / book
- 0.00
- EPS (TTM)
- 0.99
- Beta
- 1.15
- Dividend yield
- 4.47%
- Payout ratio
- 60.61%
- Profit margin
- 5.25%
- Revenue (TTM)
- 1.11B
- Revenue growth
- -5.60%
- Free cash flow
- -37.41M
- Total cash
- 210.00M
- Total debt
- 1.59B
- Return on equity
- 0.00%
- Shares outstanding
- 58.13M
- Short % of float
- 3.97%
- 50-day average
- 18.31
- 200-day average
- 15.47
Analyst view
Consensus: none
Price target (mean) 22.00 +252.0% upside
Now 6.25
- Target (low)
- 20.00
- Target (mean)
- 22.00
- Target (high)
- 26.00
Ratings (0m) 4 1 buy · 2 hold · 1 sell
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell1
Next earnings
Nov 26, 2024
Expected Nov 26, 2024. Consensus EPS estimate 0.5875.
Financials — quick view
EMBC Revenue — quarterly 271.70M
EMBC Net income — quarterly 21.10M
EMBC EPS — quarterly 0.36
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 6, 2025 | Dec 1, 2024 | 0.45 | 0.65 | +0.20 | +44.44% |
| Nov 26, 2024 | Sep 1, 2024 | 0.40 | — | — | — |
| Nov 26, 2024 | Sep 1, 2024 | 0.40 | 0.45 | +0.05 | +12.50% |
| Aug 9, 2024 | Jun 1, 2024 | 0.48 | 0.74 | +0.26 | +54.17% |
| Aug 9, 2024 | Jun 1, 2024 | 0.48 | — | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.43 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 27, 2024 | BTIG | up | Neutral | Buy |
| Jul 15, 2024 | Morgan Stanley | main | Underweight | Underweight |
| May 10, 2024 | Morgan Stanley | main | Underweight | Underweight |
| Nov 22, 2023 | Morgan Stanley | main | Underweight | Underweight |
| Oct 18, 2023 | Morgan Stanley | main | Underweight | Underweight |
| Aug 24, 2023 | Morgan Stanley | main | Underweight | Underweight |
About Embecta Corp.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- embecta.com
News
- Reviewing Rockwell Medical (NASDAQ:RMTI) & Embecta (NASDAQ:EMBC)
- EMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
- EMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
- embecta to Participate in Investor Events
- EMBECTA CORP. (EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
- The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products
- EMBECTA CORP. (EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
- EMBC Stock News: Embecta Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 57% Stock Drop
- CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026
- EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit
Your note
Sign in to keep a note on EMBC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALBRITTON DAVID | Director | Stock Award(Grant) | Feb 11, 2025 | 39,743 |
| ANDERSON CARRIE L | Director | Stock Award(Grant) | Feb 11, 2025 | 39,743 |
| CASNER JEAN | Officer | Stock Award(Grant) | Nov 25, 2024 | 48,288 |
| HOMBACH ROBERT J. CPA | Director | Stock Award(Grant) | Feb 11, 2025 | 39,749 |
| MELCHER DAVID F. | Director | Purchase | Feb 24, 2025 | 76,681 |
| MORRIS MILTON MAYO | Director | Sale | Feb 12, 2025 | 36,133 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.01% | 9,305,878 | 125.63M | Dec 30, 2024 |
| Vanguard Group Inc | 12.08% | 7,025,483 | 94.84M | Dec 30, 2024 |
| Deerfield Management Company, L.P. (Series C) | 5.63% | 3,270,535 | 44.15M | Dec 30, 2024 |
| American Century Companies Inc | 5.61% | 3,261,934 | 44.04M | Dec 30, 2024 |
| River Road Asset Management, LLC | 5.59% | 3,247,389 | 43.84M | Dec 30, 2024 |
| FMR, LLC | 4.29% | 2,491,123 | 33.63M | Dec 30, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 6.47% | 3,758,570 | 50.74M | Dec 30, 2024 |
| American Century Small Cap Value Fund | 4.18% | 2,430,000 | 32.80M | Dec 30, 2024 |
| Vanguard Total Stock Market Index Fund | 3.28% | 1,907,344 | 25.75M | Sep 29, 2024 |
| Fidelity Low-Priced Stock Fund | 2.88% | 1,676,327 | 22.63M | Oct 30, 2024 |
| AMG Yacktman Fd | 2.75% | 1,600,000 | 21.60M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.67% | 1,554,650 | 20.99M | Dec 30, 2024 |